President and Founder
The Engelke Group, LLC
KEYMAR, Maryland
Dr. Engelke is an accomplished Pharmacologist and Board Certified Toxicologist with over 28 years of experience in drug development and regulatory affairs. Dr. Engelke has extensive expertise in designing, implementing, interpreting, and reporting non-clinical and clinical studies for both large and small molecules across various therapeutic areas. Dr. Engelke has a proven track record in study design, global regulatory strategy, multidisciplinary team leadership, and comprehensive dossier evaluation. Dr. Engelke is also the founder of a non-clinical and regulatory consulting service which provides advice in guiding drug candidates from discovery to market approval.
P-052 - (Poster #52) Observations from a Rat Model of Fentanyl-Induced Changes Respiratory Function
Thursday, September 4, 2025
4:00 PM - 5:30 PM PST